Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA210567
Max Phase: Preclinical
Molecular Formula: C32H39N3O2
Molecular Weight: 497.68
Molecule Type: Small molecule
Associated Items:
ID: ALA210567
Max Phase: Preclinical
Molecular Formula: C32H39N3O2
Molecular Weight: 497.68
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
Standard InChI: InChI=1S/C32H39N3O2/c1-37-31-7-3-2-6-30(31)35-22-20-34(21-23-35)19-5-4-18-33-32(36)29-24-27-13-12-25-8-10-26(11-9-25)14-16-28(29)17-15-27/h2-3,6-11,15,17,24H,4-5,12-14,16,18-23H2,1H3,(H,33,36)
Standard InChI Key: ZKXPPFSIRYLWQE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 497.68 | Molecular Weight (Monoisotopic): 497.3042 | AlogP: 4.91 | #Rotatable Bonds: 8 |
Polar Surface Area: 44.81 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.93 | CX LogP: 6.32 | CX LogD: 5.68 |
Aromatic Rings: 3 | Heavy Atoms: 37 | QED Weighted: 0.45 | Np Likeness Score: -0.50 |
1. Schlotter K, Boeckler F, Hübner H, Gmeiner P.. (2006) Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists., 49 (12): [PMID:16759104] [10.1021/jm060138d] |
2. Schlotter K, Boeckler F, Hübner H, Gmeiner P.. (2006) Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists., 49 (12): [PMID:16759104] [10.1021/jm060138d] |
3. Schlotter K, Boeckler F, Hübner H, Gmeiner P.. (2006) Fancy bioisosteres: novel paracyclophane derivatives as super-affinity dopamine D3 receptor antagonists., 49 (12): [PMID:16759104] [10.1021/jm060138d] |
4. Skultety M, Hübner H, Löber S, Gmeiner P.. (2010) Bioisosteric replacement leading to biologically active [2.2]paracyclophanes with altered binding profiles for aminergic G-protein-coupled receptors., 53 (19): [PMID:20839776] [10.1021/jm100899z] |
Source(1):